Search

Author/Creator Raskopf, E.

1. A randomized, double‐blind, placebo‐controlled, dose‐finding trial with Lolium perenne peptide immunotherapy. Issue 4 (22nd December 2017)

Authors:
Mösges, R.; Kasche, E. M.; Raskopf, E.; Singh, J.; Sohlich, L.; Astvatsatourov, A.; Shah‐Hosseini, K.; Pirotton, S.; Haazen, L.; Durham, S. R.; Legon, T.; Zadoyan, G.; Shamji, M. H.
Journal:
Allergy
Issue:
Volume 73:Issue 4(2018)
Page Start:
896
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Lolium perenne peptide immunotherapy is well tolerated and elicits a protective B‐cell response in seasonal allergic rhinitis patients. Issue 6 (13th February 2018)

Authors:
Mösges, R.; Koch, A. F.; Raskopf, E.; Singh, J.; Shah‐Hosseini, K.; Astvatsatourov, A.; Hauswald, B.; Yarin, Y.; Corazza, F.; Haazen, L.; Pirotton, S.; Allekotte, S.; Zadoyan, G.; Legon, T.; Durham, S. R.; Shamji, M. H.
Journal:
Allergy
Issue:
Volume 73:Issue 6(2018)
Page Start:
1254
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search